Consolidated Financial Statements for the Third Quarter Ended December 31, 2020 FY2021 (April 1, 2020 - March 31, 2021)［UNAUDITED］
  • 2021/02/10
サブ-ナビゲーション
  • information
  • News
  • Corporate Guide
    • Message from the president
    • Corporate Data
    • Corporate History
    • Corporate Executives
    • Group
    • Access
  • Business
    • Reagents/Instruments
    • CDMO
    • Gene Therapy
  • Investor Relations
    • IR Library
      • Financial Results
      • Annual Securities Report
      • Annual Report
      • General Meeting of Shareholders
      • Tender Offer and Share Consolidation
    • 現在位置:IR News
    • Contact IR
  • Sustainability
    • News＆Topics
    • Policy
    • Materiality （Important Issues）
      • Safety
      • Governance
      • Environment
      • Human rights
      • Wellness
      • Human resources
      • Procurement
      • Community
    • Sustainability Topics
    • Sustainability Index
  • Contact Us
    • Contact IR

Consolidated Financial Statements for the Third Quarter Ended December 31, 2020 FY2021 (April 1, 2020 - March 31, 2021)［UNAUDITED］

  • 2021/02/10

Back to List

PAGETOP
PAGETOP
  • CLOSE
  • MENU

サイト内検索

  • footer-content
  • menu
  • JA
  • EN
  • contact
  • gnavi-box